Epigenetic alterations in colorectal carcinomas and precancerous lesions;Die rolle epigenetischer veränderungen in kolorektalen karzinomen und ihren vorläuferläsionen

Zeitschrift fur Gastroenterologie

Volumn 46, Issue 10, 2008, Pages 1202-1206

  Tischoff, Iris ^a   Tannapfel, A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Adenoma; CIMP; CIN; Colorectal carcinoma; Promoter methylation

Indexed keywords

ANTINEOPLASTIC AGENT;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CHROMOSOMAL INSTABILITY; COLON INJURY; COLORECTAL CARCINOMA; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; PHENOTYPE; REVIEW;

COLORECTAL NEOPLASMS; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECANCEROUS CONDITIONS; PREVALENCE;

EID: 55849152843     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027406     Document Type: Review

References (30)

1. Aaltonen LA, Peltomaki P, Leach FS et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-816
2. Bai AHC, Tong JHM, To KF et al. Promoter methylation of tumor-related genes in the progression of colorectal neoplasia. Int J Cancer 2004; 112: 846-853
3. Baylin SB, Esteller M, Rountree MR et al. Aberrant pattern of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001; 10: 687-692
4. Bird A, Wolffe AP. Methylation-induced repression- belts, braces and chromation. Cell 1999; 99: 451-454
5. Dong SM, Lee EJ, Park CK et al. Progressive methylation during the serrated neoplasia pathway of the colorectum. Mod Pathol 2005; 18: 170-178
6. Ehrlich M. DNA hypomethylation and cancer In: Natick (Hrsg). DNA Alteratins in Cancer: Genetic and Epigenetic Changes. Natick: Eaton Publishing, 2000: 273-291
7. van Engeland M, Roemen GMJM, Brink M et al. K-ras and RASSF1A promoter methylation in colorectal cancer. Oncogene 2002; 21: 3792-3795
8. Esteller M, Tortola S, Toyota M et al. Hypermethylation-associated inactivation of p14ARF is independent pf p16INK4a methylation and mutational status. Cancer Res 2000; 60: 129-133
9. Esteller M, Hamilton SR, Buger K et al. Inactivation of the DNA repair gene O 6-methylguanine-DNA methyltransferase by promoter methylation is a common event in primary human neoplasia. Cancer Res 1999; 59: 793-797
10. Esteller M, Toyota M, Sanchez-Cespedes M et al. Inactivation of the DNA repair gene O 6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000; 60: 2368-2371
11. Esteller M, Risques RA, Toyota M et al. Promoter hypermethylation of the DNA repair O 6-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001; 61: 4689-4692
12. Fodde R, Kuipers J, Rosenberg C et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 2001; 3: 433-438
13. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases and Cdk inhibitors in human cancer. Adv Cancer Res 1996; 68: 67-108
14. Hendrich B, Bird A. Mammalian methyltransferases and methyl CpG-binding domains: proteins involved in DNA methylation. Curr Top Microbiol Immunol 2000; 249: 55-74
15. Hibi K, Nakayama H, Koike M et al. Colorectal cancers with both p16 and p14 methylation show invasive characteristics. Jpn J Cancer Res 2002; 93: 883-887
16. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50: 113-130
17. Karpf AR, Jones DA. Reactivating the expression of methylation silenced genes in human cancers. Oncogene 2002; 35: 5496-5503
18. Kim HC, Roh SA, GA IH et al. CpC island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. J Gastroenterol Hepatol 2005; 20: 1920-1926
19. Lee S, Hwang KS, Lee HJ et al. Aberrant CpG island hypermethylation of multiple genes in colorectal colorectal neoplasia. Lab Invest 2004; 84: 884-893
20. Liggett Jr WH, Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 1998; 16: 1197-1206
21. Lind GE, Thorstensen L, Lovig T et al. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 2004; 3: 28
22. Mäkinen MJ. Colorectal serrated adenocarcinoma. Histopathology 2007; 50: 131-150
23. Raveh T, Kimchi A. DAP kinase - a proapoptotic gene that functions as a tumor suppressor. Exp Cell Res 2001; 264: 185-192
24. Shivakumar L, Minna JD, Sakamaki T et al. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 2002; 22: 4309-4318
25. Song MS, Song SJ, Ayad NG et al. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 2004; 6: 129-137
26. Sato F, Harpaz N, Shibata D et al. Hypermethylation of the p14ARF gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res 2002; 62: 1148-1151
27. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-819
28. Toyota M, Ahuja N, Ohe-Toyota M et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-8686
29. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-rumor development. N Engl J Med 1988; 19: 525-532
30. Whitehall VLJ, Walsh MD, Young J et al. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 2001; 61: 827-830